📍 WASHINGTON, ABD
16.11.2026 01:08 UTC
Singapore Focus: US FDA rejects closely watched lung cancer drug from China
Verified reporting indicates that uS FDA rejects closely watched lung cancer drug from China. Additional details from primary dispatches note: <p>The treatment, called ivonescimab, has become a symbol of China’s rise in ...